BEVAZENE

BEVAZENE

By: Enzene Biosciences Limited

Medicine; Medicines; Biochemical Medicines; Liquid Medicines; Medicine Cases, Portable, Filled; Medicines For Human Use; Medicines For Human Purposes; Antitumor Drugs; Anti-cancer Preparations; Drugs For Medical Purposes; Pharmaceuticals; Pharmaceutical Substances; Pharmaceutical Compositions; Pharmaceutical Drugs; Pharmaceutical Preparations; Ocular Pharmaceuticals; Injectable Pharmaceuticals; Pharmaceutical Substances And Preparations; Pharmaceutical And Medical Preparations; Pharmaceutical Preparations And Substances; Pharmaceuticals For Ophthalmological Use; Pharmaceutical Preparations Containing Amino Acids; Pharmaceutical Preparations For Health Care; Autoinjectors Prefilled With Pharmaceutical Preparations; Pharmaceutical Preparations For Human Purposes; Pharmaceutical Preparations For Ocular Use; Human Immune Globulin ; Pharmaceutical Preparations For Suppressing Tumours; Pharmaceutical Preparations For Human Use; Pharmaceutical Preparations Sold In Prefilled Syringes; Pharmaceutical Preparations Sold In Prefilled Injectors; Pharmaceutical Products For Use By Humans; Pharmaceutical Preparations For Use In Immunotherapies; Pharmaceutical Preparations For Treating Malignant Tumours; Pharmaceutical Preparations For Use In Ophthalmology; Pharmaceutical Preparations For Treating Metabolic Disorders; Pharmaceutical Preparations (for Treating Rheumatological Disease);pharmaceutical Preparations Containing Amino Acids; Pharmaceutical Preparations For Use In Oncology; Pharmaceuticals For The Treatment Of Cancer; Pharmaceutical Preparations For Use In Immunomodulation Therapies; Pharmaceutical Preparations For Regulating The Immune System; Pre-filled Syringes For Medical Purposes , Pharmaceutical Preparations (for The Prevention Of Ocular Disorders); Pharmaceutical Preparations For The Prevention Of Autoimmune Diseases; Pharmaceutical Preparations (for The Prevention Of Inflammatory Disorders); Pharmaceutical Preparations (for The Treatment Of Inflammatory Disorders); Pharmaceutical Preparations And Substances For Use In Oncology; Pharmaceutical Preparations For The Treatment Of Multiple Sclerosis; Pharmaceuticals For The Prevention And Treatment Of Cancer; Intravenous Fluids Used For The Delivery Of Pharmaceutical Preparations; Pharmaceutical Preparations And Substances For The Prevention Of Cancer; Pharmaceutical Preparations And Substances For The Treatment Of Cancer; Drug Delivery Agents That Facilitate The Delivery Of Pharmaceutical Preparations; Pharmaceutical Preparations For The Treatment Of Eye Diseases And Conditions; Pre-filled Syringes With Pharmaceutical Preparations For Treating Auto-immune Diseases; Pharmaceutical Preparations And Substances For The Treatment Of Metabolic Diseases And Disorders; Pharmaceutical Preparations And Substances For The Prevention Of Metabolic Diseases And Disorders; Pharmaceutical Preparations For The Treatment Of Immune System Related Diseases And Disorders; Pharmaceutical Preparations For The Prevention And Treatment Of Diseases And Disorders Of The Autoimmune System; Pharmaceutical Preparations For The Prevention And Treatment Of Diseases And Disorders Of The Metabolic System; Amino Acid Preparations For Medical Purposes; Amino Acid Preparations For Medical Use; Biotechnological Preparations For Medical Use; Medicines For Human Purposes; Pharmaceutical Compositions Containing Stem Cells; Pharmaceutical Drugs; Pharmaceutical Preparations; Pharmaceutical Preparations For Medical Purposes; Pharmaceutical Preparations For Human Use; Pharmaceutical Preparations And Substances.